The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease
Open accessAbstract
Abstract Introduction: Within six months of its emergence, SARS‑CoV‑2 has infected 5.5 million people worldwide, causing >345,000 deaths. The virus is transmitted through respiratory droplets and physical contact from contaminated surfaces to the mucosa. Hand hygiene and oral decontamination among other measures are key to preventing the spread of the virus. We report the in-vitro virucidal activity of topical and oral povidone-iodine (PVP‑I) products against SARS‑CoV‑2.Methods: Suspension assays were used to assess the virucidal activity of PVP‑I against SARS‑CoV‑2. Products were tested at a contact time of 30 seconds for virucidal activity. Viral titres were calculated using the Spearman-Kärber method and reported as TCID50/mL.Results: All four products (antiseptic solution [PVP-I 10%], skin cleanser [PVP-I 7.5%], gargle and mouth wash [PVP-I 1%] and throat spray [PVP-I 0.45%] achieved ≥99.99% virucidal activity against SARS-CoV-2, corresponding to ≥4 log10 reduction of virus titre, within 30 seconds of contact.Conclusion: This study provides evidence of rapid and effective virucidal activity of PVP-I against SARS-CoV-2. PVP-I-based products are widely available for medical and personal use for hand hygiene and oral decontamination and could be readily integrated into COVID-19 infection control measures in hospital and community settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Stability of SARS-CoV-2 in different environmental conditions
Chin, A. W. H., Chu, J. T. S., Perera, M. R. A., Hui, K. P. Y., Yen, H.-L., Chan, M. C. W., Peiris, M., & Poon, L. L. M. (2020) · doi:10.1101/2020.03.15.20036673 · Cited by 1,948 · cited 3×
“5%), indicating potential usage in disinfection procedures [7].”
InfluentialHigh Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200282 · Cited by 1,619
Kariwa, H., Fujii, N., & Takashima, I. (2006) · Dermatology · doi:10.1159/000089211 · Cited by 458
Eggers, M., Eickmann, M., & Zorn, J. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0091-9 · Cited by 229
Self-citation
Cited by
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Kurakula, M., & Rao, G. S. N. K. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102046 · Cited by 535
Metadata
- Authors
- Anderson, D. E., Sivalingam, V., Kang, A. E. Z., Ananthanarayanan, A., Arumugam, H., Jenkins, T. M., Hadjiat, Y., & Eggers, M.
- Venue
- Infectious Diseases and Therapy
- Published
- 2020-07-08
- Volume
- 9
- Issue
- 3
- Pages
- 669-675
- ISSN
- 2193-6382 (ISSN-L)
- 2193-8229
- OpenAlex
- W3042079535
- Cited by
- 177
- References
- 5
- FWCI
- 13.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. https://app.cochat.ai/papers/10.1007/s40121-020-00316-3
- The paper
- Anderson, D. E., Sivalingam, V., Kang, A. E. Z., Ananthanarayanan, A., Arumugam, H., Jenkins, T. M., Hadjiat, Y., & Eggers, M. (2020). Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Infectious Diseases and Therapy. https://doi.org/10.1007/s40121-020-00316-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.